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Epac1all GTP-binding proteins that amongst others are involved in the control of cell–
cell and cell–matrix adhesion. Several Rap guanine nucleotide exchange factors (RapGEFs) function to
activate Rap. These multi-domain proteins, which include C3G, Epacs, PDZ-GEFs, RapGRPs and DOCK4, are
regulated by various different stimuli and may function at different levels in junction formation. Downstream
of Rap, a number of effector proteins have been implicated in junctional control, most notably the adaptor
proteins AF6 and KRIT/CCM1. In this review, we will highlight the latest ﬁndings on the Rap signaling
network in the control of epithelial and endothelial cell–cell junctions.
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Rap proteins, which include Rap1 (A and B) and Rap2 (A, B and C),
are members of the Ras-like small G-proteins. These monomeric
proteins cycle between a GTP-bound (active) conformation and a
GDP-bound (inactive) one, thereby allowing signaling pathways to be
quickly switched on or off. GTP-binding is facilitated by guanine
nucleotide exchange factors (GEFs) that release GDP and allow the
more abundant GTP to bind. Inactivation is catalyzed by GTPase
activating proteins (GAPs) that enhance the hydrolysis of GTP [1]. Thell rights reserved.prototypic Ras family members (H-, K- and N-Ras) function in
signaling cascades that impinge on proliferation, differentiation and
apoptosis. As such, these proteins have great oncogenic potential and
are indeed found mutated in 15% of all human cancers [2]. In a screen
for suppressors of this transforming activity, Noda and colleagues
identiﬁed Rap1A as a protein with Ras reverting potential [3]. Rap1A
carries an effector domain that is very homologous to that of Ras,
suggesting that Rap1A might directly inhibit Ras signaling by
competition for Ras effectors. Nowadays, it is commonly accepted
that Rap1A as well as the very homologous Rap1B signals largely
independently of Ras. Rap1-induced inhibition of transformation by
Ras is due to its central role in a signaling network that controls cell
polarity [4] and strengthening of cell attachment to both extracellular
matrix and neighbouring cells [5]. We have recently reviewed the
central role of Rap1 in cell–cell adhesion [6], but much progress has
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with a focus on the role of the various RapGEFs in junction formation.
Epithelia function as physical barriers that regulate transport of
substances from and towards underlying tissues. As such, it is
essential that the epithelial layer forms an intact sheet, the individual
cells of which are tightly attached to one another. Two main cell–cell
anchorage systems function to maintain epithelial barrier; the apical
tight junction (TJ) and the closely associated adherens junction (AJ)
[7]. TJs link neighbouring cells closely together, thereby creating a
physical barrier for ions and solutes. Also, TJs limit diffusion of
membrane proteins, thereby contributing to apical–basolateral polar-
ity [8]. AJs increase monolayer rigidity by linking the actin networks of
neighbouring cells. The central core of AJs is the homophilic
interaction of cadherin proteins. Cadherins are single-pass transmem-
brane glycoproteins of which the extracellular domains interact with
opposing cadherins in a calcium-dependent manner. E-cadherin
constitutes the AJs of epithelial cells, whereas endothelium expresses
the closely related VE-cadherin. Intracellularly, (V)E-cadherin inter-
acts with catenin family members. p120-catenin binds to the
juxtamembrane region of (V)E-cadherin to stabilize its plasma
membrane localization, whereas α- and β-catenin serve a dynamic
role in linking (V)E-cadherin to the actin cytoskeleton [9].
A landmark paper by Knox and Brown for the ﬁrst time linked Rap1
to AJ formation. In Drosophila melanogaster, rap1 localizes to the AJ.
Rap1 mutant cell clones have aberrant shapes and intermingle with
surrounding wild-type cells, indicating a defect in mutual cell–cell
adhesion, whereas adhesion to wild-type cells occurs properly.
Apical–basolateral polarity is maintained and the formation of septate
junctions, which are considered to be analogous to TJs, seems
unaffected. However, the junctional proteins DE-cadherin, α-catenin
and β-catenin lose their even, circumferential distribution and localize
in clusters at one side of the cell [10]. In MDCK cells, dominant
negative Rap1 prevents cells from attaching to Fc-E-cadherin.
Conversely, disruption of cell–cell contacts by scatter factor (HGF)
can be completely inhibited by activation of endogenous Rap1 [11].
Forcing Rap1 into its inactive conformation by ectopic expression of
RapGAP does not disrupt mature cell–cell contacts, but dramatically
affects junction reformation in a calcium-switch model [12]. Similarly,
cells depleted of Rap1A by siRNA only show defective junction
formation after replating [13]. Together, these data clearly establishFig. 1. Schematic representation of the domain structure of RapGEFs. cAMP: cyclic AMP-bind
REM: domain with unknown function present in most GEFs for Ras-like proteins; DOCK: do
DAG-binding domain; PLCXc: phospholipase C catalytic domain, domain X; PLCYc: phospho
binding domain.Rap1 as a key regulator of adherens junctions and suggest it functions
in the formation process instead of junction maintenance.
2. RapGEFs in junction formation
The notion that Rap1 is involved in the establishment of cell–cell
contacts implies that Rap1 is being activated before or during contact
formation. Using a FRET-based Rap1 activation construct, activation of
Rap1 was found at newly formed cell–cell contacts [14]. Others have
used a calcium switch model, in which chelation of extracellular
calcium is used to break up the calcium-dependent transinteraction of
E-cadherin proteins. Following add-back of calcium, AJs reform
synchronously, allowing for biochemical assays. Indeed, Rap1 is
activated during early junction reformation and this activation
decreases when junctions are restored [15]. These data are in line
with the observations that Rap1 functions in junction formation.
Intriguingly, activation of Rap1 has also been reported upon disrup-
tion of adherens junctions [16]. It is well possible that disruption of AJs
serves as a trigger to activate Rap1, thereby inducing junction
reformation to maintain epithelial integrity. A ﬁrst clue to understand
this pattern of Rap1 activation may come from the characterization of
the Rap1-speciﬁc GEFs. To date, six major classes of highly conserved
GEFs are discriminated (Fig. 1): C3G (RapGEF1), PDZ-GEFs (RapGEF2
and -6), Epac proteins (RapGEF3, -4 and -5), members of the RasGRP
family (RasGRP2 and 3), Phospholipase C epsilon and the atypical
RapGEF DOCK4. Four of these GEF families have been implicated in
junction regulation.
C3G was the ﬁrst RapGEF identiﬁed with a characteristic catalytic
region consisting of a CDC25 homology domain and a Ras exchange
motif (REM). Furthermore, it contains proline-rich sequences which
bind to the SH3 domain of the adaptor proteins Crk and Grb2. C3G
directly interacts with E-cadherin during the initial steps of junction
formation [12]. This binding is mutually exclusive with binding of β-
catenin to E-cadherin, suggesting that C3G does not bind E-cadherin
in mature AJs. Importantly, inhibition of C3G inhibits translocation of
E-cadherin to the junctions, indicating a key role of this GEF in the
recruitment of E-cadherin [12]. C3G localizes to endosomes [17] and
has been proposed to activate Rap1 on intracellular membrane
compartments upon internalization of the EGF receptor [18]. Similarly,
Rap1 activation can be triggered by E-cadherin internalization [16],ing domain; cNB-L: cyclic nucleotide binding domain like; RA: Ras-association domain;
main present in proteins with putative GEF function; EF: calcium binding domain; C1:
lipase C catalytic domain, domain Y; C2; Ca2+ binding motif. ⁎ putative extra nucleotide
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induce E-cadherin translocation. C3G was also found to mediate Rap1
activation after engagement of nectins [19]. Nectins are immunoglo-
bulin-like transmembrane proteins that form homophilic and hetero-
philic dimers via their extra-cellular domains, which have been
proposed to induce the formation of AJs [20]. Nectins bind to c-Src at
cell–cell contact sites, causing Src activation and subsequent recruit-
ment of C3G [19]. C3G-induced Rap1 activation might also be the
switch that stabilizes junctions upon mechanical stress. Indeed,
stretching of cells activates Rap1 [21] in a C3G-dependent manner
[22]. Interestingly, p130Cas was identiﬁed as the ﬁrst stretch-sensing
protein [23] and is well known to form a complex with C3G [24],
suggesting p130Cas serves as a sensor that activates Rap1 upon
stretching of cells. Whether this mechanism functions in stabilization
of cell–cell contacts remains to be determined.
Also the PDZ-GEFs localize to cell junctions and are thus good
candidates for Rap1 regulation at these sites. These multidomain
proteins have a REM-CDC25 homology domain as catalytic region, a
PDZ domain and regions homologous to cyclic nucleotide binding
domains. PDZ-GEF1 associates with β-catenin both directly and via
the scaffold proteins MAGI-1 and MAGI-2 [14,25,26]. MAGI-1 is
localized at cell–cell junctions and is required for contact-induced
activation of Rap1, presumably by PDZ-GEF1, although this has yet to
be proven [14]. Rap1 activation upon loss of AJs does depend on PDZ-
GEF1. The authors propose that PDZ-GEF/Rap1 mediate the repair of
AJ [27]. D. melanogaster contains a single PDZ-GEF protein and ﬂies
that carry mutant dPDZ-GEF show strong dorsal closure defects.
However, the AJ components Arm (β-catenin) and DE-cadherin were
evenly distributed around the circumference of dPDZ-GEF mutantFig. 2. Model of the differential roles for RapGEFs in junction formation. Activation of Rap1
membrane and subsequent formation of the initial cell–cell junctions. Secondly, activation o
the actin cytoskeleton. Finally, Epac1 induces tightening of endothelial junctions upon cA
unknown protein that links AJ and actin cytoskeleton.cells, indicating that AJ integrity is not perturbed by the loss of dPDZ-
GEF function. Interestingly, extensions at the lateral cell periphery do
point towards a defect in contractility, suggesting that dPDZ-GEF
could enhance cell–cell contact tightening by acting on the actomyo-
sin machinery [28].
Recently, PDZ-GEF2 was identiﬁed as an essential activator of Rap1
during junction formation both in epithelial and endothelial cells. In
contrast to cells inhibited for C3G, cells depleted of PDZ-GEF2 have
only slightly decreased E-cadherin levels at the cell surface. However,
they do not form mature junctions upon replating, which can be
rescued by active Rap1A [13]. This indicates that PDZ-GEF2 functions
at a different level in junction formation as C3G (Fig. 2).
A main question remains how PDZ-GEFs are activated. PDZ-GEF1
contains one cyclic nucleotide-binding domain and PDZ-GEF2 even
two. However, no effect was observed of cyclic nucleotides on Rap1
activation by PDZ-GEF [29,30]. In neurons, neurotrophins activate
PDZ-GEF1 during neurite outgrowth [31] and in splenocytes TNFα-
induced M-Ras activates PDZ-GEF2 [32]. Similarly, PDZ-GEF1 is
activated and translocated by GTP-bound Rap1 [33]. Therefore, PDZ-
GEFs might well function in reiterative GTPase activation and/or
positive feedback loops.
DOCK4 is a member of the atypical RhoGEFs, which is found
mutated in a subset of human tumors [34]. DOCK4 has GEF activity for
both Rap and Rac. Osteosarcoma cells lacking DOCK4 do not form
intercellular junctions, but this can be rescued by expression of an
active Rap1 mutant, indicating a role for DOCK4 as a RapGEF in
junction formation [34]. Recently, it was shown that DOCK4 is
activated by RhoG and regulates cell migration via the activation of
Rac [35]. Whether RhoG also activates DOCK4 in junction formation isthrough C3G and/or DOCK4 is involved in the recruitment of E-cadherin to the plasma
f PDZ-GEF is required for the maturation of junctions, presumably through regulation of
MP stimulation in an actin-dependent manner. β: β-catenin; p120: p120-catenin; ?:
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upon trans-endothelial-migration of leukocytes, a process which
requires reorganization of endothelial cell–cell junctions [36].
Lastly, junctional Rap1 can be activated by Epac1. The Epac proteins
contain, in addition to the REM-CDC25 homology domain, one or two
cAMP binding domains, a DEP (Dishevelled, EGL-10, Pleckstrin)
domain and a Ras association (RA) domain. Regulation of junction
integrity in endothelial cells by cAMP/ Epac1 is discussed below.
Thus, various RapGEFs are involved in the regulation of cell–cell
junctions to activate Rap proteins. These GEFs sense different changes
in cell surrounding, like cell–cell contact formation, mechanical stress
and leukocyte transmigration.
3. Rap1 in junction formation
Regulation of adherens junctions mainly occurs at two levels: ﬁrst,
tight control exists on the vesicular sorting of E-cadherin, determining
its cell surface levels. Second, signaling cascades control the
cytoskeletal linkage to E-cadherin, thereby stabilizing the contact
[37,38]. Rap1A and Rap1B seem to impinge on both of them in a way
that may well be isoform speciﬁc [13].
An interesting link between Rap1 and E-cadherin levels was
recently found in the nematode C. elegans. Homozygous RAP-1mutant
worms show delayed, but normal development [39]. In a genome-
wide synthetic lethal screen, ral-1, sec-5 and exoc-8 were found to be
essential for viability of RAP-1 mutant worms [40]. The mammalian
orthologues of these proteins, Ral, Sec5 and Exo84 are known to
function in a single signaling cascade that regulates plasmamembrane
delivery of E-cadherin [41,42]. When fed with RNAi targeting exocyst
complex members, RAP-1 mutant embryos show an arrest in
hypodermal cell migration, similar to mutants defective in the
cadherin–catenin complex [40,43]. The synthetic lethality of Rap1
with the exocyst members suggests that Rap1 functions to stabilize E-
cadherin at the cell membrane, the key regulator of which is p120-
catenin. Binding of p120-catenin to the juxtamembrane region of E-
cadherin prevents E-cadherin internalization [44]. Interestingly, the
Rap1 effector AF6 associates with p120-catenin and this binding
increases the interaction of p120-catenin with E-cadherin. AF6
prevents non-trans-interacting E-cadherin from being removed from
junctions in an in vitro assay only when bound to Rap1 or upon
deletion of the Ras binding domain from AF6 [45], but dynamics of the
AF6/p120-catenin link and its regulation by Rap1 have not been
further characterized.
Once E-cadherin homophilically interacts with E-cadherin on
neighbouring cells, these proteins become trapped and start signal-
ing to increase cell–cell contact area. These signaling cascades result
in dynamic regulation of the cytoskeleton to strengthen the junction
(reviewed in [37]). In brief, PI-3-kinase and p120-catenin dependent
activation of Rac drives actin dynamics that result in contact
extension. Next, the contact is strengthened by direct linkage of
the cadherin complex to the actin cytoskeleton. This requires a
transition from branched actin to actin cables, brought about by
inhibition of Arp2/3 and recruitment of Ena/VASP proteins. This
switch is thought to be regulated by dimers of α-catenin. Lastly,
trans-interacting E-cadherin induces recruitment and microtubule-
dependent phosphorylation of Myosin II, which mediates actomyosin
contraction, ultimately resulting in the formation of the typical
zonula adherens of polarized epithelial cells [37]. Intermediate stages
of junction formation have been visualized in primary keratinocytes,
showing E-cadherin-rich ﬁlopodial extensions that protrude towards
neighbouring cells to form ‘adhesion zippers’ [46,47]. Interestingly,
junction formation of A549 lung carcinoma cells depleted of Rap1A
halts at a stage with very similar adhesion zippers. Ultra-structural
analysis of the junctions in Rap1A-depleted cells indicates the
presence of ﬁlopodial extensions that have failed to zipper up.
Importantly, surface E-cadherin level was unaltered, suggesting adefect in the cytoskeleton-mediated strengthening of the junctions
[13]. Adhesion zippers have also been observed upon inhibition of
Arp2/3-mediated actin assembly [48] and in cells depleted of EPLIN,
a protein that links the cadherin–catenin complex to F-actin [49].
Together, these reports clearly point to a role of Rap1 in regulating
cytoskeletal dynamics to induce extension of nascent contacts. This is
in line with observations in mice selectively expressing a dominant-
negative Rap1 in differentiating spermatids. These spermatids have
normal surface expression of VE-cadherin, but linkage of VE-cadherin
to the cytoskeleton is impaired [50].
Thus, Rap1 is clearly important in cell–cell contacts. Interestingly,
expressing RapGAP or siRap1A does not perturb a conﬂuent mono-
layer [12,13]. This suggests that the prime function of Rap1 is in
junction formation rather than junction maintenance. However,
rap1 mutant cells in a Drosophila wing have perturbed AJs [10] and
C. elegans RAP-1 seems to stabilize E-cadherin at the cell surface [40],
both pointing at a role in maintenance. Possibly, Rap1 serves a subtle
role in AJ maintenance that only becomes apparent during certain
stages of development and/or conditions that require a quick re-
establishment of cell–cell contacts.
Several actin modulating proteins have been shown to be directly
regulated by Rap1. First of all, Rap1 can signal to GTPases of the Rho
family that are well known for their effects on the actin cytoskeleton
and thereby affect cell–cell contacts as well [51]. Rap1 has been shown
to induce Rac activation [52] and to mediate relocalization of the
RacGEFs Vav2 and Tiam1 during cell spreading [53]. Within the
context of junction formation it has been found that a fast-cycling
mutant of Cdc42 rescues the effects of RapGAP [12]. Furthermore,
TIAM is essential for cell–cell contact maturation [54,55] and nectin
engagement activates both Rac and Cdc42 via their respective GEFs
Vav2 and FRG in a C3G/Rap1 dependent manner [19,56]. However,
how Rap controls junctions through Rho GTPases is currently elusive.
RIAM binds to activated Rap1 and is essential for Rap1 to induce
adhesion of T-cells to extracellular matrix [57]. RIAM contains several
proline-rich stretches that bind VASP proteins [58] and the actin
elongation factor Proﬁlin. Indeed, RIAM induces actin polymerization
[57], but its role in junction maturation has not been investigated. In
a recent proteomics paper, double-tag puriﬁcation of Rap1A
identiﬁed Ena and VASP as speciﬁc binding partners [59]. Ena/
VASP proteins are essential for several modes of actin modulation at
cell–cell contact sites [60], but a functional connectivity with Rap1
has yet to be established.
Another connection of Rap1 to the actin cytoskeleton may be
through AF6. This Rap effector binds to a number of junctional
proteins, including nectin, ZO-1 and p120. Indeed, AF6 functions to
stabilize E-cadherin at the membrane (see above). Furthermore, AF6
directly interacts with actin to mediate E-cadherin dependent cell–
cell adhesion. However, the latter functions occurs independently of
Rap1 binding [61].
4. Rap1 signalling in endothelial junctions
The endothelium is a highly specialized cell layer that surrounds
the entire circulatory system. It controls capillary permeability and
diapedesis of leukocytes. As such, the endothelium functions as an
important regulator of body homeostasis [62]. The regulation of
vascular permeability requires very strict control of junctional
integrity. Hence, both assembly and disassembly of endothelial cell–
cell contacts are under tight hormonal control [63]. Interestingly,
barrier stabilizing agents generally increase intracellular levels of the
second messenger cAMP. Dynamic control of endothelial cell–cell
junctions by cAMP is mediated by both PKA and Epac1 via
independent pathways [64].
Epac proteins are cAMP-responsive GEFs for the Rap family of
GTPases. They have been implicated in several physiological processes,
such as inﬂammatory response, secretion, Ca2+ signaling, apoptosis,
Fig. 3.Overview scheme of Rap1 signalling in cell–cell contacts. See text for details. RTK:
Receptor Tyrosine Kinase; GPCR: G-protein coupled receptor; p120: p120-catenin; β:
β-catenin; MT: microtubules.
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greatly facilitated by the characterization of an Epac-speciﬁc cAMP
analogue, 8-pCPT-2′-O-Me-cAMP (007) [67]. Treatment of an
endothelial monolayer with 007 decreases both basal and thrombin-
induced permeability [68–70] and increases trans-endothelial elec-
trical resistance (TER) [15]. Physiological induction of cAMP in
pulmonary endothelial cells by prostaglandins or atrial natriuretic
peptide (ANP) similarly increases TER in a manner depending on both
PKA and Epac1 [71,72].
The importance of Epac1/Rap1 in cell–cell contact tightening has
been conﬁrmed in vivo. Intradermal injection of 007 prevents both
basal and VEGF-induced leakage of Evans Blue from blood vessels [69].
In perfusion experiments with rat venular microvessels, 007 treat-
ment attenuated PAF (platelet activating factor) induced increase in
permeability [73], suggesting that cAMP/Epac1/Rap1 blocks increase
in vascular permeability via regulation of the AJ in vivo.
Several Rap1 effector proteins might mediate the effect on barrier
function. As described above, Rac signaling is likely to be downstream
of Rap1 and this holds for endothelial cells as well. Similar to Epac1,
the RacGEFs Vav2 and Tiam1 are required for ANP and PGE2 induced
TER increase [71,72]. Rac1 is activated and translocates to cell–cell
contacts when monolayers are stimulated with 007 [74], indicating
that Rap1 functions to modulate Rac activity. Recently, the Rap1
binding protein KRIT1 (K-Rev1 Interaction Trapped gene 1, also known
as CCM1) was shown to be involved in Epac1/Rap1-induced
permeability of endothelial cell–cell junctions [75]. Together with
CCM2/MGC4607 and CCM3/PDCD10, KRIT1 constitutes a set of
proteins, mutations of which are found in cerebral cavernous
malformations. These neurological disorders are characterized by
cerebral hemorrhages and vascular malformations in the central
nervous system [76]. Mice lacking KRIT1 die because of vascular
defects [77] and loss of KRIT1 or CCM2 in zebraﬁsh embryos results in
severe dilation of the major vessels [78]. Originally, KRIT1 was
identiﬁed as an interactor of Rap1 in yeast-two-hybrid assays [79]. In
conﬂuent endothelial monolayers, KRIT1 localizes to cell–cell con-
tacts, where it is found in a complex containing the AJ proteins VE-
cadherin, β-catenin, α-catenin, p120-catenin, AF6, but not the tight
junction marker ZO-1. Depletion of KRIT1 by siRNA disables Epac1/
Rap1 to rescue thrombin-induced permeability, establishing KRIT1 as
an effector of Rap1 in the tightening of cell-cell contacts. It remains to
be elucidated how KRIT1 relays the Rap1 signal towards cell–cell
contacts. KRIT1 associates with β-catenin and AF6 in a Rap1-
dependent way and siRNA targeting KRIT1 disrupts junctional staining
of β-catenin [75], suggesting KRIT1might stabilize β-catenin at the AJ.
Alternatively, KRIT1 regulates endothelial cell shape by microtubule
(MT) targeting [80]. Indeed, KRIT1 binds to MTs, which is inhibited by
active Rap1. Furthermore, Rap1 activation is associated with increased
membrane binding of KRIT1, suggesting that KRIT1 is targeted to the
membrane by microtubules where it is captured by Rap1 [81].
Recently, it was shown that Epac1-induced increase in TER of
HUVEC monolayers is sensitive to the microtubule disrupting agent
nocodazole. Ectopic YFP-Epac1 localizes tomicrotubules, independent
of its activation status. Treatment with 007 induced elongation of
microtubules towards the cell periphery. Thismicrotubule growthwas
also observed in single cells or after overexpression of Rap1GAP,
indicating that Epac1 exerts its effect onMTs independent of junctions
and Rap1 [82]. Intriguingly, Epac1 binding to MTs seems to suppress
activation of Rap1 [83], and disruption of MTs stabilizes cell–cell
contacts by increasing the junctional pool of β-catenin [84]. Indeed, β-
catenin can be removed from the cell periphery by its associationwith
the MT motor protein dynein [85]. Other junctional proteins can be
regulated by MTs as well; p120-catenin binds MTs [86] and focal
accumulation of E-cadherin was perturbed by nocodazole [87]. Taken
together, these results suggest Epac1 might function as a switch in
junction dynamics via its direct effects on MTs and Rap1-mediated
effects on actin.5. Concluding remarks
It is clear that the Rap signaling network plays a critical role in both
de novo formation and dynamic regulation of cell–cell junctions.
Several RapGEFs and Rap1 effector proteins have been proposed to
mediate these processes (Fig. 3). A picture emerges in which a certain
GEF is preferentially utilized during formation or during remodeling of
junctions in a cell type speciﬁc manner. Indeed, each of these GEFs is
equipped with unique protein domains that are tailored to regulate or
localize a GEF under speciﬁc conditions. For example, the dynamic
nature of adherens junctions in endothelial cells is under the control
of the second messenger cAMP and the cAMP-regulated GEF Epac1.
PDZ-GEFs may be more important for remodeling junctions during
e.g. migration of sheets of cells or junction maturation since it
interacts directly with proteins present in junctions like MAGI. While
Epac and PDZ-GEF may impinge on a similar process – the
stabilization of junctions – C3G and perhaps DOCK4 function in the
control of E-cadherin recruitment.
Clearly many questions are still unanswered. For instance, how are
the various RapGEFs regulated in time and space to control a dynamic
process as junction formation and maintenance? What is the
interconnectivity between these GEFs? For instance, PDZ-GEF1 is a
GEF for Rap1 but also a Rap1 effector. Is this a direct feedback loop or is
this a connection with other GEFs? What is the role of the various
Rap1GAPs? Are they general negative regulators or are they also under
tight control? Also, what are the critical downstream targets of Rap1
and what is the molecular mechanism by which they control junction
formation? It is likely that multiple effectors mediate the Rap effects.
Some effectors may regulate vesicular transport, some cytoskeletal
dynamics and others may be involved in the connection between the
cytoskeleton and junctional proteins. If so, what is the interconnec-
tivity between these different effectors? Finally, most studies point to
a major role of Rap1 in junction formation, but since most of the
795W.-J. Pannekoek et al. / Biochimica et Biophysica Acta 1788 (2009) 790–796RapGEFs also activate Rap2, it is important to include this family of
proteins in the analyses as well.
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